ADCT ADC Pharma: Nilai Akuntansi saben Saham

Biotechnology startup ADC Therapeutics (ADCT) relies on the work of research laboratories, strictly adhering to hazardous waste disposal standards and energy efficiency. ADC Therapeutics (ADCT) is developing a targeted tumor destruction system through innovative antibody-drug conjugates, establishing itself as a leader in therapy. The -1.81 metric complements data on social responsibility and testing ethics. This price chart clearly illustrates the market dynamics of this developer of blood cancer drugs.

ADC Therapeutics S.A. (ADCT) - Nilai Akuntansi saben Saham saka 04.07.2022 nganti 27.10.2026

Ringkesan rincian data analitis adctherapeutics.com (ADCT)

- rega lan prakiraan konsensus rega:

Rega saham ADC Therapeutics Corp|ADCT - Target konsensus

- data kapitalisasi pasar:

Biji pasar ADC Therapeutics SA|ADCT - Total Nilai Bisnis

- data kapitalisasi buku:

Nilai Buku saben Saham ADC Therapeutics|ADCT - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku adctherapeutics.com|ADCT - Total Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas ADC Therapeutics|ADCT - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal ADC Therapeutics SA|ADCT - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku ADC Therapeutics SA

Analisis kabeh metrik perusahaan:ADC Therapeutics Corp, ADCT

Produk asil prodhuksi adctherapeutics.com

Book value per share reflects the issuer's net assets minus liabilities, representing a fundamental "floor" for the business valuation. By analyzing the book value per share, an investor can assess the actual resource backing of ADC Therapeutics (ADCT), which is critically important given the company's high cash burn and its struggle for market share in the oncology drug segment.

Analisis pesaing ADC Therapeutics